Docusign (NASDAQ: DOCU) recently received a number of ratings updates from brokerages and research firms:
- 6/5/2026 – Docusign was given a new $60.00 price target by UBS Group AG.
- 6/5/2026 – Docusign had its price target raised by Citigroup Inc. from $50.00 to $54.00. They now have a “neutral” rating on the stock.
- 6/5/2026 – Docusign had its price target lowered by Wells Fargo & Company from $60.00 to $55.00. They now have an “equal weight” rating on the stock.
- 6/5/2026 – Docusign had its price target raised by Jefferies Financial Group Inc. from $45.00 to $50.00. They now have a “hold” rating on the stock.
- 6/5/2026 – Docusign had its price target lowered by Wedbush from $60.00 to $58.00. They now have a “neutral” rating on the stock.
- 6/5/2026 – Docusign had its price target lowered by BTIG Research from $70.00 to $60.00. They now have a “buy” rating on the stock.
- 6/5/2026 – Docusign had its “hold” rating reaffirmed by Needham & Company LLC.
- 6/3/2026 – Docusign was upgraded by Weiss Ratings from “sell (d+)” to “hold (c-)”.
- 4/15/2026 – Docusign was downgraded by Weiss Ratings from “hold (c-)” to “sell (d+)”.
Insider Activity at Docusign
In other Docusign news, CRO Paula Hansen sold 6,000 shares of the company’s stock in a transaction dated Wednesday, April 1st. The stock was sold at an average price of $46.84, for a total transaction of $281,040.00. Following the sale, the executive owned 79,233 shares in the company, valued at $3,711,273.72. This represents a 7.04% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider James P. Shaughnessy sold 12,000 shares of the stock in a transaction dated Wednesday, April 1st. The shares were sold at an average price of $46.83, for a total value of $561,960.00. Following the completion of the transaction, the insider owned 53,631 shares in the company, valued at approximately $2,511,539.73. The trade was a 18.28% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 65,489 shares of company stock worth $3,125,814 over the last quarter. 0.59% of the stock is currently owned by insiders.
DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.
Recommended Stories
- Five stocks we like better than Docusign
- Everpure: AI Storage Uncertainty Overshadows Breakneck Growth
- This Tech ETF Is Beating QQQ—and Canada May Be Part of the Reason
- Intel Is the Market’s Most Mispriced AI Hedge
- The Biggest Opportunity From SpaceX’s IPO May Surprise You
Receive News & Ratings for Docusign Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign Inc and related companies with MarketBeat.com's FREE daily email newsletter.
